BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Diagnosis
15 results:

  • 1. Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine Lymphoma to Human breast cancer.
    Hochman J; Braitbard O
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366533
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Recent Advances in Epidermal Growth Factor Receptor Inhibitors (EGFRIs) and their Role in the Treatment of cancer: A Review.
    Unnisa A; Chettupalli AK; Hussain T; Kamal MA
    Anticancer Agents Med Chem; 2022; 22(20):3370-3381. PubMed ID: 35400324
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal cancer: A Review.
    Strickler JH; Yoshino T; Graham RP; Siena S; Bekaii-Saab T
    JAMA Oncol; 2022 May; 8(5):760-769. PubMed ID: 35238866
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Impact of TAILORx on chemotherapy prescribing and 21-gene recurrence score-guided treatment costs in a population-based cohort of patients with breast cancer.
    Tesch ME; Speers C; Diocee RM; Gondara L; Peacock SJ; Nichol A; Lohrisch CA
    Cancer; 2022 Feb; 128(4):665-674. PubMed ID: 34855202
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Human epidermal growth factor receptor 2-positive metastatic breast cancer with novel epidermal growth factor receptor -ZNF880 fusion and epidermal growth factor receptor E114K mutations effectively treated with pyrotinib: A case report.
    Yue L; Wentao L; Xin Z; Jingjing H; Xiaoyan Z; Na F; Tonghui M; Dalin L
    Medicine (Baltimore); 2020 Dec; 99(51):e23406. PubMed ID: 33371069
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Emerging ways to treat breast cancer: will promises be met?
    Samadi P; Saki S; Dermani FK; Pourjafar M; Saidijam M
    Cell Oncol (Dordr); 2018 Dec; 41(6):605-621. PubMed ID: 30259416
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer.
    D'Aloisio AA; Nichols HB; Hodgson ME; Deming-Halverson SL; Sandler DP
    BMC Cancer; 2017 Oct; 17(1):692. PubMed ID: 29058598
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. breast imaging after dark: patient outcomes following evaluation for breast abscess in the emergency department after hours.
    Bosma MS; Morden KL; Klein KA; Neal CH; Knoepp US; Patterson SK
    Emerg Radiol; 2016 Feb; 23(1):29-33. PubMed ID: 26433916
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Proteolytic processing of erbb4 in breast cancer.
    Hollmén M; Liu P; Kurppa K; Wildiers H; Reinvall I; Vandorpe T; Smeets A; Deraedt K; Vahlberg T; Joensuu H; Leahy DJ; Schöffski P; Elenius K
    PLoS One; 2012; 7(6):e39413. PubMed ID: 22761786
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.
    Chiu CG; Masoudi H; Leung S; Voduc DK; Gilks B; Huntsman DG; Wiseman SM
    Ann Surg; 2010 Jun; 251(6):1107-16. PubMed ID: 20485140
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry--possibilities and limitations.
    Vollmann-Zwerenz A; Diermeier-Daucher S; Wege AK; Sassen A; Schmidt-Brücken E; Hofstaedter F; Ortmann O; Nauwelaers F; Brockhoff G
    Cytometry A; 2010 Apr; 77(4):387-98. PubMed ID: 20151455
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The her4/4ICD estrogen receptor coactivator and BH3-only protein is an effector of tamoxifen-induced apoptosis.
    Naresh A; Thor AD; Edgerton SM; Torkko KC; Kumar R; Jones FE
    Cancer Res; 2008 Aug; 68(15):6387-95. PubMed ID: 18676864
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
    Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Amplification of erbB-4 oncogene occurs less frequently than that of erbB-2 in primary human breast cancer.
    Vogt U; Bielawski K; Schlotter CM; Bosse U; Falkiewicz B; Podhajska AJ
    Gene; 1998 Nov; 223(1-2):375-80. PubMed ID: 9858771
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior.
    Bacus SS; Zelnick CR; Chin DM; Yarden Y; Kaminsky DB; Bennington J; Wen D; Marcus JN; Page DL
    Am J Pathol; 1994 Dec; 145(6):1337-48. PubMed ID: 7992839
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.